BRIEF published on 11/18/2024 at 08:05, 3 days 5 hours ago Cairn Homes Executes Share Buyback Plan Share Buyback Market Abuse Regulation Stock Exchange Cairn Homes Deutsche Numis
PRESS RELEASE published on 11/18/2024 at 08:00, 3 days 5 hours ago Cairn Homes Plc: Transaction in Own Shares Cairn Homes Plc announces the purchase and cancellation of 274,332 ordinary shares on Euronext Dublin and the London Stock Exchange as part of its share buyback program London Stock Exchange Ordinary Shares Share Buyback Cairn Homes Plc Euronext Dublin
BRIEF published on 11/15/2024 at 08:05, 6 days 5 hours ago Cairn Homes Completes Share Buyback Transaction London Stock Exchange Share Buyback Euronext Dublin Cairn Homes Deutsche Numis
PRESS RELEASE published on 11/15/2024 at 08:00, 6 days 5 hours ago Cairn Homes Plc: Transaction in Own Shares Cairn Homes Plc purchased 87,383 of own ordinary shares on Euronext Dublin and London Stock Exchange. Shares will be cancelled as part of buyback program London Stock Exchange Ordinary Shares Cairn Homes Plc Euronext Dublin Buyback Program
BRIEF published on 11/14/2024 at 08:05, 7 days 5 hours ago Cairn Homes Plc: Share Buyback Details London Stock Exchange Ordinary Shares Share Buyback Euronext Dublin Cairn Homes
PRESS RELEASE published on 11/14/2024 at 08:00, 7 days 5 hours ago Cairn Homes Plc: Transaction in Own Shares Cairn Homes Plc announces the purchase and cancellation of 269,915 ordinary shares as part of its buyback program. Details of the transaction on Euronext Dublin and London Stock Exchange provided London Stock Exchange Share Buyback Cairn Homes Plc Euronext Dublin Transaction
BRIEF published on 11/13/2024 at 08:05, 8 days 5 hours ago Cairn Homes Plc Buys Back Over 314,000 Shares London Stock Exchange Share Buyback Euronext Dublin Cairn Homes Market Regulation
PRESS RELEASE published on 11/13/2024 at 08:00, 8 days 5 hours ago Cairn Homes Plc: Transaction in Own Shares Cairn Homes Plc purchased 314,353 of its own ordinary shares on Euronext Dublin and the London Stock Exchange. Shares will be cancelled as part of the buyback program London Stock Exchange Share Buyback Cairn Homes Plc Euronext Dublin Numis Securities Ltd
BRIEF published on 11/12/2024 at 13:15, 9 days ago Major Holdings Change in Cairn Homes Plc Voting Rights Major Holdings Lansdowne Partners Cairn Homes Shareholder Notification
PRESS RELEASE published on 11/12/2024 at 13:10, 9 days ago Cairn Homes Plc: Holding(s) in Company Cairn Homes Plc: Notification of major holdings by Lansdowne Partners International Limited, Lansdowne Partners Limited, and Lansdowne Partners (UK) LLP on 12/11/2024 Voting Rights Cairn Homes Plc Major Holdings Notification Lansdowne Partners
Published on 11/21/2024 at 13:30, 14 minutes ago AirIQ Announces September 30, 2024 Quarterly Results Company Reports Double-Digit Growth in Recurring Revenue
Published on 11/21/2024 at 13:30, 14 minutes ago Datametrex Secures Additional P.O. Approx $250K for IT Services
Published on 11/21/2024 at 13:00, 44 minutes ago Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Published on 11/21/2024 at 13:00, 44 minutes ago Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Published on 11/21/2024 at 13:00, 44 minutes ago Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography
Published on 11/21/2024 at 12:35, 1 hour 9 minutes ago audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 29 minutes ago Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 06:58, 6 hours 46 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 24 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 19 hours 59 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 19 hours 59 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 5 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
